2011
DOI: 10.1155/2011/697162
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand

Abstract: Hepatocellular carcinoma (HCC) may develop according to two major pathways, one involving HBV infection and TP53 mutation and the other characterized by HCV infection and CTNNB1 mutation. We have investigated HBV/HCV infections and TP53/CTNNB1 mutations in 26 HCC patients from Thailand. HBV DNA (genotype B or C) was detected in 19 (73%) of the cases, including 5 occult infections and 3 coinfections with HCV. TP53 and CTNNB1 mutations were not mutually exclusive, and most of TP53 mutations were R249S, suggestin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 42 publications
1
14
0
1
Order By: Relevance
“…It was quite similar to a study of Northeast Peninsular Malaysia in which HBV was recorded in 57.6% but less HCV, 2.4%, of HCC study (Norsa'adah et al, 2013) and in some parts of Thailand where HBV was identified between 40-65% of HCC cases, and HCV was recognized in 16-17% of cases (Samboon et al, 2014;Galy et al, 2011;Tangkijvanich et al, 2003). In Vietnam, a study found that HBV was detected in 60.5% of HCC cases and HCV was discovered in 2.6% of the cases (Ding et al, 2003).…”
Section: Discussionsupporting
confidence: 86%
“…It was quite similar to a study of Northeast Peninsular Malaysia in which HBV was recorded in 57.6% but less HCV, 2.4%, of HCC study (Norsa'adah et al, 2013) and in some parts of Thailand where HBV was identified between 40-65% of HCC cases, and HCV was recognized in 16-17% of cases (Samboon et al, 2014;Galy et al, 2011;Tangkijvanich et al, 2003). In Vietnam, a study found that HBV was detected in 60.5% of HCC cases and HCV was discovered in 2.6% of the cases (Ding et al, 2003).…”
Section: Discussionsupporting
confidence: 86%
“…A recent estimate of the risk of HCC attributable to aflatoxin for Thailand has provided figures of 0.53–0.73 and 15.9–21.9/10 5 person years, in HBsAg-negative and positive subjects, respectively [11]. In a recent study on a small group of surgically resected HCC patients at the National Cancer Institute, Bangkok, we reported R249S mutation in 7/26 (27%) cases, suggesting that the contribution of AFB 1 to the burden of HCC in Thailand is far from negligible [15]. However, an earlier epidemiological study in Thailand using a albumin-adduct biomarker to assess aflatoxin exposure, failed to identify an aflatoxin-associated risk for HCC [16].…”
Section: Introductionmentioning
confidence: 83%
“…38 A recent study of a small group of surgically resected HCC patients at the National Cancer Institute, Bangkok reported a R249S mutation in 7/26 (27%) cases, suggesting that the contribution of AFB1 to the burden of HCC in Thailand is far from negligible. 39 In contrast, an earlier epidemiological study in Thailand using a albuminadduct biomarker to assess aflatoxin exposure failed to identify an aflatoxin associated risk for HCC. 40 …”
Section: Role Of Aflatoxin Afb1mentioning
confidence: 94%